GIANCANE, GABRIELLA
 Distribuzione geografica
Continente #
EU - Europa 3.751
AS - Asia 195
SA - Sud America 25
NA - Nord America 24
AF - Africa 7
Totale 4.002
Nazione #
IT - Italia 3.740
SG - Singapore 86
CN - Cina 47
VN - Vietnam 47
US - Stati Uniti d'America 18
BR - Brasile 14
HK - Hong Kong 5
AR - Argentina 4
MX - Messico 4
DE - Germania 3
IQ - Iraq 3
ZA - Sudafrica 3
EC - Ecuador 2
MA - Marocco 2
RU - Federazione Russa 2
VE - Venezuela 2
AM - Armenia 1
AT - Austria 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
FI - Finlandia 1
FR - Francia 1
ID - Indonesia 1
IN - India 1
IR - Iran 1
KZ - Kazakistan 1
LB - Libano 1
NL - Olanda 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 4.002
Città #
Genova 1.907
Genoa 1.134
Rapallo 377
Vado Ligure 313
Singapore 27
Ho Chi Minh City 15
Beijing 11
Hanoi 10
Bordighera 5
Haiphong 5
Hong Kong 5
San Jose 5
Ashburn 4
Biên Hòa 3
Council Bluffs 3
Da Nang 3
Mexico City 3
Tianjin 3
Agadir 2
Changsha 2
Los Angeles 2
Nuremberg 2
São Paulo 2
Araçoiaba 1
Baghdad 1
Barueri 1
Basra 1
Benito Juarez 1
Blumenau 1
Boston 1
Bắc Giang 1
Cairo 1
Cajamarca 1
Campo Limpo Paulista 1
Cape Town 1
Caracas 1
Cascavel 1
Des Moines 1
Dubnica nad Váhom 1
Erbil 1
Esmeraldas 1
Frankfurt am Main 1
Gualeguaychú 1
Guayaquil 1
Hải Dương 1
Islamabad 1
Jijoca de Jericoacoara 1
Jundiaí 1
Lappeenranta 1
Maringá 1
Minaçu 1
Montevideo 1
Moscow 1
Nha Trang 1
Odintsovo 1
Palu 1
Panama City 1
Pavlodar 1
Phú Thọ 1
Pietermaritzburg 1
Pretoria 1
Puerto Cabello 1
Punta Alta 1
Quảng Ngãi 1
Rio de Janeiro 1
Rome 1
Salem 1
Salto 1
Santa Fe 1
Santo Domingo 1
Shanghai 1
Shenzhen 1
Tehran 1
Thái Bình 1
Tumba 1
Vilhena 1
Villa Ángela 1
Vinh 1
Yerevan 1
Zarzal 1
Totale 3.900
Nome #
Juvenile Idiopathic Arthritis: Diagnosis and Treatment 198
Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritis. 173
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis 158
Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases 156
IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis 156
Clinical outcome measures in juvenile idiopathic arthritis 151
Pharmacovigilance in juvenile idiopathic arthritis patients (pharmachild) treated with biologic agents and/or methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) registry 149
Recent therapeutic advances in juvenile idiopathic arthritis 142
A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis 140
Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever 140
Disease activity and damage in juvenile idiopathic arthritis: Methotrexate era versus biologic era 136
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries 136
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study 135
Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis. 132
Update on the pathogenesis and treatment of juvenile idiopathic arthritis 130
Temporomandibular joint involvement in juvenile idiopathic arthritis: Reliability and validity of a screening protocol for the rheumatologist 128
EULAR recommendations for the management of familial Mediterranean fever 127
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients 116
Primary hypertrophic osteoarthropathy: An update on patient features and treatment 116
Determinants of discordance between criteria for inactive disease and low disease activity in juvenile idiopathic arhritis 113
Information technology in paediatric rheumatology 108
Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis 107
Treatment of juvenile idiopathic arthritis: what's new? 102
Paediatric rheumatic disease: What is the best definition of clinical remission in JIA? 100
Open issues in the assessment and management of pain in juvenile idiopathic arthritis 97
Temporomandibular Joint Involvement is Associated with Quality of Life, Disability and High Disease Activity in Juvenile Idiopathic Arthritis 97
The Effect of Morning Stiffness Duration on the Definition of Clinically Inactive Disease in Juvenile Idiopathic Arthritis 92
Growth and puberty in juvenile dermatomyositis: a longitudinal cohort study 91
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis 85
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: Post hoc radiographic analysis from two randomized controlled trials 80
A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis 78
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis 74
Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee 73
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 61
Outcome Scores in Pediatric Rheumatology 42
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study 17
Totale 4.136
Categoria #
all - tutte 15.549
article - articoli 15.142
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.691


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021323 0 0 0 0 0 28 85 32 37 52 41 48
2021/2022411 16 12 18 32 15 40 15 81 43 52 20 67
2022/2023442 36 42 8 41 87 61 1 39 72 2 48 5
2023/2024257 18 36 4 40 22 19 19 15 16 13 10 45
2024/2025814 32 52 35 60 74 74 85 165 23 43 90 81
2025/2026590 212 28 53 58 191 48 0 0 0 0 0 0
Totale 4.136